Precision Biosciences (DTIL) Long-Term Investments (2021 - 2026)
Precision Biosciences has reported Long-Term Investments over the past 6 years, most recently at $744000.0 for Q1 2026.
- Quarterly Long-Term Investments fell 76.79% to $744000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $744000.0 through Mar 2026, down 76.79% year-over-year, with the annual reading at $744000.0 for FY2025, 76.79% down from the prior year.
- Long-Term Investments was $744000.0 for Q1 2026 at Precision Biosciences, roughly flat from $744000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $3.2 million in Q4 2023 and troughed at $744000.0 in Q2 2025.
- The 5-year median for Long-Term Investments is $2.6 million (2022), against an average of $2.2 million.
- Year-over-year, Long-Term Investments surged 280.67% in 2022 and then plummeted 76.79% in 2025.
- A 5-year view of Long-Term Investments shows it stood at $2.6 million in 2022, then grew by 24.46% to $3.2 million in 2023, then changed by 0.0% to $3.2 million in 2024, then plummeted by 76.79% to $744000.0 in 2025, then changed by 0.0% to $744000.0 in 2026.
- Per Business Quant, the three most recent readings for DTIL's Long-Term Investments are $744000.0 (Q1 2026), $744000.0 (Q4 2025), and $744000.0 (Q3 2025).